El-Deiry WS - Search Results

1

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.

Winer A, Denlinger CS, Vijayvergia N, Cohen SJ, Astaturov I, Dotan E, Gallant JN, Wang EW, Kunkel M, Lim B, Harvey HA, Sivik J, Korzekwa K, Ruth K, White K, Cooper HS, Ross EA, Zhou L, El-Deiry WS. Winer A, et al. Clin Colorectal Cancer. 2021 Mar;20(1):e43-e52. doi: 10.1016/j.clcc.2020.08.003. Epub 2020 Aug 19. Clin Colorectal Cancer. 2021. PMID: 32972830 Free article. Clinical Trial.

2

Multispectral fluorescence imaging.

Zhou L, El-Deiry WS. Zhou L, et al. J Nucl Med. 2009 Oct;50(10):1563-6. doi: 10.2967/jnumed.109.063925. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759119 Free article. Review.

3

Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.

Wang W, Gallant JN, Katz SI, Dolloff NG, Smith CD, Abdulghani J, Allen JE, Dicker DT, Hong B, Navaraj A, El-Deiry WS. Wang W, et al. Cancer Biol Ther. 2011 Aug 1;12(3):229-38. doi: 10.4161/cbt.12.3.17033. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21725212

4

Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer.

Gallant JN, Allen JE, Smith CD, Dicker DT, Wang W, Dolloff NG, Navaraj A, El-Deiry WS. Gallant JN, et al. Cancer Biol Ther. 2011 Aug 1;12(3):239-51. doi: 10.4161/cbt.12.3.17034. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21725213

5

Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.

Zhou L, Wang W, Dicker DT, Humphreys RC, El-Deiry WS. Zhou L, et al. Cancer Biol Ther. 2011 Aug 15;12(4):335-48. doi: 10.4161/cbt.12.4.17174. Epub 2011 Aug 15. Cancer Biol Ther. 2011. PMID: 21785270

6

Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients.

Kline CL, Sheikh HS, Scicchitano A, Gingrich R, Beachler C, Finnberg NK, Liao J, Sivik J, El-Deiry WS. Kline CL, et al. Cancer Biol Ther. 2011 Oct 1;12(7):557-68. doi: 10.4161/cbt.12.7.18059. Epub 2011 Oct 1. Cancer Biol Ther. 2011. PMID: 21931273 Clinical Trial.

7

Extracellular protease imaging for cell mass tracking of xenografted human malignant pleural mesothelioma.

Zhou L, El-Deiry W, Wang W, Ingram ME, Katz SI. Zhou L, et al. Oncol Rep. 2012 Sep;28(3):883-8. doi: 10.3892/or.2012.1888. Epub 2012 Jun 26. Oncol Rep. 2012. PMID: 22751990

8

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation.

Cheng H, Hong B, Zhou L, Allen JE, Tai G, Humphreys R, Dicker DT, Liu YY, El-Deiry WS. Cheng H, et al. Cell Cycle. 2012 Sep 1;11(17):3312-23. doi: 10.4161/cc.21670. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22895172 Free PMC article.

9

The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer.

Allen JE, Gallant JN, Dicker DT, Amin S, Irby RB, Sharma AK, El-Deiry WS. Allen JE, et al. PLoS One. 2013;8(3):e59380. doi: 10.1371/journal.pone.0059380. Epub 2013 Mar 12. PLoS One. 2013. PMID: 23555026 Free PMC article.

10

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device.

Gallant JN, Matthew EM, Cheng H, Harouaka R, Lamparella NE, Kunkel M, Yang Z, Harvey HA, Cream LV, Kumar SM, Robertson GP, Zheng S, Drabick JJ, Truica CI, El-Deiry WS. Gallant JN, et al. Cell Cycle. 2013 Jul 1;12(13):2132-43. doi: 10.4161/cc.25165. Epub 2013 Jun 11. Cell Cycle. 2013. PMID: 23759587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

490 results

Search Page